Laura L Fernandes (Laura Fernandes)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

Blood cancer journal

Cancer medicine

Blood

U.S. Food and Drug Administration

This page only lists publications with an associated author ORCID identifier.

Affiliation History

U.S. Food and Drug Administration Jun 14 2014

United States

Statistician :: Biostatistics

Publications

Helmneh M Sineshaw, Christina M Zettler, Jennifer Prescott, Mahek Garg, Samhita Chakraborty, Eric M Sarpong, Claire Bai, Andrew J Belli, Laura L Fernandes, Ching-Kun Wang
Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy. Cancer medicine 13 (7) (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elaine Chang, Jiaxi Zhou, Chi Song, Haley Gittleman, Laura L Fernandes, Chana Weinstock, Michael B Atkins, Sundeep Agrawal, Rajeshwari Sridhara, Nicole J Gormley, Shenghui Tang, Daniel L Suzman, Laleh Amiri-Kordestani, Paul G Kluetz, Richard Pazdur, Brian I Rini, David F McDermott, Meredith M Regan
A Pooled Analysis of Treatment-Free Survival in Advanced Renal Cell Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Helmneh M Sineshaw, Christina M Zettler, Jennifer Prescott, Mahek Garg, Samhita Chakraborty, Eric M Sarpong, Claire Bai, Andrew J Belli, Laura L Fernandes, Ching-Kun Wang
Real-world patient characteristics, treatment patterns, and treatment outcomes of patients with diffuse large B-cell lymphoma by line of therapy. Cancer medicine 13 (7) (2024)
Bindu Kanapuru, Laura L Fernandes, Andrea C Baines, Rachel Ershler, Vishal Bhatnagar, Elizabeth Pulte, Thomas Gwise, Marc R Theoret, Richard Pazdur, Lola A Fashoyin-Aje, Nicole Gormley
Eligibility criteria and Enrollment of a Diverse Racial and Ethnic population in Multiple Myeloma Clinical Trials. Blood (2023)
Kathleen Maignan, Lola A Fashoyin-Aje, Aracelis Z Torres, Laura L Fernandes, Thomas Gwise, Shrujal B Baxi, James P Roose, Donna R Rivera, Yuan Li Shen, Paul G Kluetz, Nicole J Gormley
Exploring racial disparities in treatment patterns and outcomes for patients with multiple myeloma using real world data. Blood cancer journal 12 (4) (2022)
Laura L Fernandes, Jiaxi Zhou, Bindu Kanapuru, Erica Horodniceanu, Thomas Gwise, Paul G Kluetz, Vishal Bhatnagar
Review of patient-reported outcomes in multiple myeloma registrational trials: highlighting areas for improvement. Blood cancer journal 11 (8) (2021)
Preeti Narayan, Tatiana M Prowell, Jennifer J Gao, Laura L Fernandes, Emily Li, Xiling Jiang, Junshan Qiu, Jianghong Fan, Pengfei Song, Jingyu Yu, Xinyuan Zhang, Bellinda L King-Kallimanis, Wei Chen, Tiffany K Ricks, Yutao Gong, Xing Wang, Katherine Windsor, Steve Y Rhieu, Gerlie Geiser, Anamitro Banerjee, Xiaohong Chen, Francisca Reyes Turcu, Deb K Chatterjee, Anand Pathak, Jeffrey Seidman, Soma Ghosh, Reena Philip, Kirsten B Goldberg, Paul G Kluetz, Shenghui Tang, Laleh Amiri-Kordestani, Marc R Theoret, Richard Pazdur, Julia A Beaver
FDA Approval Summary: Alpelisib Plus Fulvestrant for Patients with HR-positive, HER2-negative, PIK3CA-mutated, Advanced or Metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 27 (7) (2020)

Laura L Fernandes.css-eqlu8i{font-size:small;padding-left:4px;} (Laura Fernandes)

Publication Activity (10 Years)

Top Topics

Top Venues

Laura L Fernandes (Laura Fernandes)